ACK
OGN icon

Andrew C. Karlinski’s Organon & Co OGN Stock Holding History

Andrew C. Karlinski’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-83
Closed -$2K – 167
2022
Q3 		$2K Sell
83
-1
-1% -$30 ﹤0.01% 228
2022
Q2 		$3K Buy
84
+83
+8,300% +$2.91K ﹤0.01% 242
2022
Q1 		$0 Buy
+1
New +$34 ﹤0.01% 362

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Andrew C. Karlinski's OGN Position: Q4 2022 in Review

Andrew C. Karlinski sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 83 shares — an estimated $2K sold.

Andrew C. Karlinski first reported a position in OGN in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 822 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Andrew C. Karlinski reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Andrew C. Karlinski sold 83 Organon & Co shares in Q4 2022, an estimated $2K.
  • Andrew C. Karlinski first reported a position in Organon & Co in Q1 2022 and held it in 3 quarters.
  • Andrew C. Karlinski's Organon & Co position peaked at $3K in Q2 2022.
  • 822 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Andrew C. Karlinski's 13F filing for Q4 2022.